DNTH Competitors & Alternatives
Compare Dianthus Therapeutics Inc. with similar stocks in the same industry
Biotechnology
DNTH
Main Stock$96.86
Tradestie Score
59
Market Cap
$1.55B
Revenue Growth
-0.6%
Analyst Upside
+31.8%
Top Competitors
232 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ABVX
Abivax SA American Depositary Shares
|
$136.35
|
$6.38B | - | 56 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$25.92
|
$6.03B | - | 52 | Compare |
|
CRSP
CRISPR Therapeutics AG
|
$51.63
|
$6.02B | - | 53 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.96
|
$5.95B | - | 59 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$226.37
|
$5.92B | - | 60 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$54.97
|
$5.80B | 20.0 | 61 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$359.47
|
$5.20B | 50.3 | 60 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$57.07
|
$4.94B | - | 60 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$81.51
|
$4.93B | - | 63 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$73.63
|
$4.84B | - | 46 | Compare |
More DNTH Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2834)
232 stocks in this industry